BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37119823)

  • 1. Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records.
    Baksh RA; Pape SE; Chan LF; Aslam AA; Gulliford MC; Strydom A;
    Lancet Public Health; 2023 Jun; 8(6):e453-e462. PubMed ID: 37119823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and medication in a large population of individuals with Down syndrome compared to the general population.
    Alexander M; Petri H; Ding Y; Wandel C; Khwaja O; Foskett N
    Dev Med Child Neurol; 2016 Mar; 58(3):246-54. PubMed ID: 26282180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Conrad N; Misra S; Verbakel JY; Verbeke G; Molenberghs G; Taylor PN; Mason J; Sattar N; McMurray JJV; McInnes IB; Khunti K; Cambridge G
    Lancet; 2023 Jun; 401(10391):1878-1890. PubMed ID: 37156255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General health status in young people with intellectual disabilities with and without Down syndrome in, and transitioning from, special education: findings from the National Longitudinal Transitions Study-2.
    Rydzewska E; Fleming M; Mackay D; Young-Southward G; Blacher J; Bolourian Y; Widaman K; Cooper SA
    J Intellect Disabil Res; 2020 Dec; 64(12):895-907. PubMed ID: 33047429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study.
    Kinnear D; Morrison J; Allan L; Henderson A; Smiley E; Cooper SA
    BMJ Open; 2018 Feb; 8(2):e018292. PubMed ID: 29431619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort profile: Scotland's record-linkage e-cohorts of people with intellectual disabilities, and autistic people (SCIDA).
    Cooper SA; Henderson A; Kinnear D; Mackay D; Fleming M; Smith GS; Hughes-McCormack LA; Rydzewska E; Dunn K; Pell JP; Melville C
    BMJ Open; 2022 May; 12(5):e057230. PubMed ID: 35568493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of epilepsy among people with intellectual disabilities: A systematic review.
    Robertson J; Hatton C; Emerson E; Baines S
    Seizure; 2015 Jul; 29():46-62. PubMed ID: 26076844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study.
    Montoliu-Gaya L; Alcolea D; Ashton NJ; Pegueroles J; Levin J; Bosch B; Lantero-Rodriguez J; Carmona-Iragui M; Wagemann O; Balasa M; Kac PR; Barroeta I; Lladó A; Brum WS; Videla L; Gonzalez-Ortiz F; Benejam B; Arranz Martínez JJ; Karikari TK; Nübling G; Bejanin A; Benedet AL; Blesa R; Lleó A; Blennow K; Sánchez-Valle R; Zetterberg H; Fortea J
    EBioMedicine; 2023 Apr; 90():104547. PubMed ID: 37002988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of dementia indicating signs in adults with intellectual disabilities.
    Arvio M; Bjelogrlic-Laakso N
    J Appl Res Intellect Disabil; 2021 Nov; 34(6):1463-1467. PubMed ID: 33932064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause and cause-specific mortality among people with and without intellectual disabilities during the COVID-19 pandemic in the Netherlands: a population-based cohort study.
    Cuypers M; Koks-Leensen MCJ; Schalk BWM; Bakker-van Gijssel EJ; Leusink GL; Naaldenberg J
    Lancet Public Health; 2023 May; 8(5):e356-e363. PubMed ID: 37075779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid Enrollment and Service Use Among Adults With Down Syndrome.
    Rubenstein E; Michals A; Wang N; Scott A; Tewolde S; Levine AA; Tripodis Y; Skotko BG
    JAMA Health Forum; 2023 Aug; 4(8):e232320. PubMed ID: 37566429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities.
    Ptomey LT; Walpitage DL; Mohseni M; Dreyer Gillette ML; Davis AM; Forseth B; Dean EE; Waitman LR
    J Intellect Disabil Res; 2020 Sep; 64(9):725-737. PubMed ID: 32716138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A
    Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of dementia in older adults with intellectual disabilities.
    Strydom A; Chan T; King M; Hassiotis A; Livingston G
    Res Dev Disabil; 2013 Jun; 34(6):1881-5. PubMed ID: 23578903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health comorbidities and cognitive abilities across the lifespan in Down syndrome.
    Startin CM; D'Souza H; Ball G; Hamburg S; Hithersay R; Hughes KMO; Massand E; Karmiloff-Smith A; Thomas MSC; ; Strydom A
    J Neurodev Disord; 2020 Jan; 12(1):4. PubMed ID: 31973697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of fractures in people with intellectual disabilities over the life course: a retrospective matched cohort study.
    Frighi V; Smith M; Andrews TM; Clifton L; Collins GS; Fuller A; Roast J; Holt TA
    EClinicalMedicine; 2022 Oct; 52():101656. PubMed ID: 36313144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates, causes, place and predictors of mortality in adults with intellectual disabilities with and without Down syndrome: cohort study with record linkage.
    Cooper SA; Allan L; Greenlaw N; McSkimming P; Jasilek A; Henderson A; McCowan C; Kinnear D; Melville C
    BMJ Open; 2020 May; 10(5):e036465. PubMed ID: 32423940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mental health conditions, sensory impairments and physical disability in people with co-occurring intellectual disabilities and autism compared with other people: a cross-sectional total population study in Scotland.
    Dunn K; Rydzewska E; Fleming M; Cooper SA
    BMJ Open; 2020 Apr; 10(4):e035280. PubMed ID: 32341043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health characteristics and consultation patterns of people with intellectual disability: a cross-sectional database study in English general practice.
    Carey IM; Shah SM; Hosking FJ; DeWilde S; Harris T; Beighton C; Cook DG
    Br J Gen Pract; 2016 Apr; 66(645):e264-70. PubMed ID: 26906630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.